Myasthenia Gravis
NEJM 375:2570-2581, Gilhus, N.E.,et al, 2016
Myasthenia Gravis and Sarcoidosis:Report of 2 Cases
Eur Neurol 36:326-327, DeBleecker,J.,et al, 1996
Recurrent Transverse Myelitis, Myasthenia Gravis, and Autoantibodies
Ann Neurol 32:407-409, Lindsey,J.W.,et al, 1992
Genetic Factors in Myasthenia Gravis:A Family Study
Neurol 38:38-42, Kerzin-Storrar,L.,et al, 1988
HLA & Neurologic Fisease
Neurol 28:413, Compston,A., 1978
Cause of Weakness in Myasthenia Gravis
NEJM 294:722, Grob,D., 1976
Clinical Manifestations of the anti-IgLON5 Disease
Neurol 88:1736-1743,1688, Gaig, C.,et al, 2017
HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans
NEJM 364:1134-1143, McCormack,M.,et al, 2011
HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans
NEJM 364:1126-1133, Chen,P.,et al, 2011
Juvenile Dermatomyositis and Other Idiopathic Inflammatory Myopathies of Childhood
Lancet 371:2201-2212, Feldman,B.M.,et al., 2008
Narcolepsy With Cataplexy
Lancet 369:499-511, Dauvilliers,Y.,et al, 2007
Behcet's Disease
NEJM 341:1284-1291, Sakane,T.,et al, 1999
Narcolspey
NEJM 323:389-394, Aldrich,M.S., 1990
Cellular Immunity In Guamanians with Amyotrophic Lateral Sclerosis & Parkinsonism-Dementia
NEJM 299:680-685, Hoffman,P.M.,et al, 1978